Recombinant Human IL-1Ra Protein

A DNA sequence encoding the Human IL-1Ra Protein(P18510)(Arg26-Glu177)was expressed with a polyhistidine tag at the N-terminus.

Introducing the Recombinant Human IL-1RA Protein, a cutting-edge biotechnological advancement in the field of immunology. This highly purified and bioactive protein is meticulously engineered using state-of-the-art recombinant DNA technology, ensuring its exceptional quality and efficacy.

The Recombinant Human IL-1RA Protein is a potent antagonist of interleukin-1 (IL-1), a pro-inflammatory cytokine that plays a crucial role in various inflammatory diseases. By competitively binding to the IL-1 receptor, this protein effectively inhibits the IL-1 signaling pathway, thereby mitigating the inflammatory response and offering therapeutic benefits.

With its remarkable purity and bioactivity, the Recombinant Human IL-1RA Protein exhibits exceptional stability and functionality, making it an ideal choice for research and clinical applications. Its consistent and reliable performance guarantees accurate and reproducible results, enabling scientists and healthcare professionals to delve deeper into the mechanisms of inflammation and develop innovative therapeutic interventions.

This product is meticulously manufactured in compliance with stringent quality control measures, ensuring its conformity to the highest industry standards. Each batch undergoes rigorous testing to guarantee its purity, potency, and absence of contaminants, ensuring utmost safety and reliability.

The Recombinant Human IL-1RA Protein is supplied in a lyophilized form, preserving its stability and extending its shelf life. It can be easily reconstituted in a suitable buffer, allowing for convenient and efficient utilization in various experimental setups.

In summary, the Recombinant Human IL-1RA Protein represents a breakthrough in immunological research and clinical applications. Its exceptional purity, bioactivity, and stability make it an indispensable tool for scientists and healthcare professionals alike, facilitating advancements in the understanding and treatment of inflammatory diseases.